Clinical Trial Update: Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab

View source ↗

Summary

This clinical trial update investigates cardiotoxicity risk from trastuzumab in breast cancer patients by using cardiac magnetic resonance imaging to monitor he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Unity Health Toronto | Conditions: Stage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic) | Status: UNKNOWN